Contract Specifications

Instrument Type Underlying Expiry Date Option Type Strike Price Market Lot

Price Information

Last Price Today's Change Underlying value
 0.00   [0]  0.00
 
Open  0.00
Prev Close  0.00
Today's Range  0.00 - 0.00
Average Price  0.00
Buy(size)  0.00
Sell(size)  0.00

Turnover Open Interest Information

Volume Turnover Open Interest Change in OI %Change in OI
 0.00  0.00  0.00   [0.00]   [0]
FIIs trend in derivatives
Instruments Buy[Rs.Cr] Sell[Rs.Cr] Net Positions [Rs.Cr] Contracts ['000s] OI Value[Rs.Cr]
Index Futures 1,369.63 2,197.61 [827.98] 258.78 10,518.55
Index Options 10,515.80 9,607.38 908.42 1,493.47 60,433.08
Stock Futures 1,699.20 2,458.38 [759.18] 1,293.08 48,186.30
Stock Options 1,669.68 1,653.66 16.02 60.64 2,238.82
News

Markets close on a negative note; Jet Airways surges

India Infoline News Service Mar-25-2019

Jet Airways surged ~12% along with a sharp rise in open interest consisting mainly of long positions

Varun Beverages gets CCI nod for acquisition of franchise rights from PepsiCo India

India Infoline News Service Mar-25-2019

With this company received franchise rights in South and West regions from PepsiCo for a national bottling, sales and distribution footprint in 7 states and 5 Union Territories.

Sun Pharma clarifies on Baska facility inspection report; stock down 2%

India Infoline News Service Mar-25-2019

The pharma major claimed that there is no material impact of this article on the company.

Jet Airways gains 13% amid reports of founder's exit

India Infoline News Service Mar-25-2019

The current CEO Vinay Dube of the debt-ridden airline company is expected to stay on and steer Jet out of the current crisis.

Nifty Media declines 3% led by Dish TV, Den, Zee Media

India Infoline News Service Mar-25-2019

However, sharp fall in the index was cushioned by Hathway, which spurted 14% followed by Jagran Prakashan up 1%.

Lupin gets FDAs approval for Sildenafil Tablets USP

India Infoline News Service Mar-25-2019

Sildenafil Tablets are a phosphodiesterase-5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction (ED).